| 硼替佐米治疗多发性骨髓瘤临床应用进展 |
| |
| 引用本文： | 谭亚敏,黄河. 硼替佐米治疗多发性骨髓瘤临床应用进展[J]. 肿瘤学杂志, 2006, 12(4): 342-344 |
| |
| 作者姓名： | 谭亚敏 黄河 |
| |
| 作者单位： | 浙江大学医学院附属第一医院,浙江,杭州,310006 |
| |
| 摘 要： | 硼替佐米作为一种新型的蛋白酶体抑制剂,临床上可用于治疗复发性、难治性或初治的多发性骨髓瘤。该文综述了硼替佐米治疗多发性骨髓瘤的临床应用进展。
|
| 关 键 词： | 硼替佐米 蛋白酶体抑制剂 多发性骨髓瘤 |
| 文章编号： | 1671-170X（2006）04-0342-03 |
| 收稿时间： | 2006-07-14 |
| 修稿时间： | 2006-07-24 |
Clinical Progress on Bortezomib in the Treatment for Multiple Myeloma |
| |
| TAN Ya-min,HUANG He. Clinical Progress on Bortezomib in the Treatment for Multiple Myeloma[J]. Journal of Chinese Oncology, 2006, 12(4): 342-344 |
| |
| Authors: | TAN Ya-min HUANG He |
| |
| Affiliation: | The Affiliated First Hospitol of Medicol College, Zhejiong University, Hongzhou 310006, China |
| |
| Abstract: | Bortezomib is a new proteasome inhibitor. Clinical studies demonstrat that bortezomib plays role in the treatment for relapsed, refractory and initially treated multiple myeloma. Clinical progress on bortezomib in the treatment for multiple myeloma was reviewed. |
| |
| Keywords: | bortezomib proteasome inhibitor multiple myeloma |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
